blinatumomab,inotuzumab
astellas pharmaceuticals,amgen,ucb,pfizer
['leusm', 'blinatumomab', 'inotuzumab', 'improve ', 'leukemia']
congress #eha22 | presented the poor outcomes in adult pts with r/r ph- b-all after failure to both inotuzumab ozogamicin &amp; blinatumomab (n=65). hsct may improve outcomes in pts who respond to subsequent salvage therapy. #allsm #leusm #leukemia 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm